Vestiage (VEST) Is On The Qwest For 1,000,000 Men

VEST Stock, Vestiage Inc.Biotech players and low float lovers are slowly starting to pay closer attention to the penny stock of Vestiage, Inc. (VEST). Fresh off the filing of their inaugural year’s annual report, the healthy balanced sellers of wellness and anti-aging supplements has both women and men as their targeted audience to continue capturing. With a short supply of shares available in the open market, VEST stock could shoot past $1 with ease as soon as some more eyes start pulling up the level 2 screen on it and see just how thin it is.

Our Next Pick Is Coming Soon!
HERE To Make Sure You Don’t Miss Any Of Our Hot Penny Stock Alerts!

Vestiage Inc., VEST, VEST Stock, VEST Stock Quote, VEST Stock Chart, Low Float Penny Stocks To Watch, Biotech Stocks To Watch,RegiMEN,Monterey Bay NutraceuticalsVEST Stock Quote

Market Cap: 34.29M
Last: 0.78 ▼ -0.10 (-11.36%)
Volume: 3,339
Dollar Volume: $2,480
Open: 0.72
High: 0.90
Low: 0.72
Trades: 6
Authorized: 500,000,000
Issued and Outstanding: 43,960,731
14-Day Rel Strength: 32.60%
1st Resistance Point: 0.88
1st Support Level: 0.70

Looking for the Best Penny Stocks to Buy?
HERE To Receive FREE Penny Stock Alerts

Operating out of Newport Beach, California, Vestiage made a decent mark on the natural supplement market in their first year of doing sales to the point where taking notice of them is worth the effort. Creating two distinct product lines, RegiMEN™ for men and Monterey Bay Nutraceuticals™ for women, the year ended December 31, 2013, although it wasn’t profitable, can be notched as a major step in the right direction.

As per the annual report filed last week, Vestiage ended 2013 with cash on hand of $235,185 and inventory worth $74,452 which made up the bulk of the $432,396 worth of current assets. With total assets worth $1,945,252, other than the notes payable valued at $1,200,000, the current liabilities of just $62,939 seems like a mere drop in the bucket even though they are more than twice the amount of revenues, $24,603, Vestiage booked for 2013.

The reason why Vestiage looks poised for a breakout of sorts this year is mainly due to their aggressive marketing efforts which CEO, Scott Kimball, explains in the company’s PR issued March 11. Scott talks about how the company is using national radio and preparing for national television to get their products to consumers after successfully launching an integrated direct response execution team which grew male customers from 8 new customers a day in early January to 30 a day after 8 weeks.

The details of the aggressive marketing campaign only get better from there as Scott is quoted saying “we want 1 million men actively on the monthly continuity program, receiving their RegiMEN every month. At $56 per month, per man and 80%+ gross margins, you can do the math.”

Whether you can do that math in your head or not, it calculates out to VEST stock being way too undervalued for the type of Q1, 2014 Vestiage is experiencing. Seeing as how they have accomplished their recent growth without having to increasing their media spend, seeing VEST stock in the $1 range and volume due to pick up is simply only a waiting game now.

hot penny stocks, hot OTC stocks, best OTC stocks, best penny stocks

About VEST Stock

Vestiage, Inc. is a development stage, fully integrated, multi-channel sales, marketing, and distribution company specializing in bringing science-based products to the healthy aging premium consumer.

Click here to view the financial filings for VEST.
Click here to view the website for Vestiage.

Last 5 Trading Sessions:

Date Open High Low Last Change % Change Volume
03/17/14 0.7200 0.9000 0.7200 0.7800 -0.1000 -11.36% 3,300
03/14/14 0.8900 0.8900 0.8800 0.8800 -0.0100 -1.12% 2,300
03/13/14 0.8200 1.0000 0.8200 0.8900 -0.1100 -11.00% 10,400
03/11/14 0.8000 1.0000 0.7500 1.0000 unch unch 3,100
03/10/14 1.0000 1.0000 1.0000 1.0000 -0.0100 -0.99% 400


Bottom Line:

The baby boomers are a bigger market then most people think and the fight to keep looking and feeling young is a battle which has been fought for generations since the existence of mirrors. Penny stock traders who like to play these biotech, low floaters should take note of VEST and start monitoring the level 2 screens in search of a good entry point. It would be hard for VEST stock to resist $1 if they can prove in their Q1 filing that revenues for the 3 months ended March 31, 2014 matched or exceeded all of 2013 thanks to their aggressive marketing.

facebookTwitterStay Connected With Us: 

Our Next Pick Is Coming Soon!
Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!

Last updated by at .